These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 22682926)

  • 21. Supraclavicular metastasis in prostate cancer detected with 18F-fluorocholine PET/CT.
    Núñez Miller R; Viera JC; Jover Díaz R; Rojo Sebastián A; Pozo MA; Alfonso Alfonso JM
    Rev Esp Med Nucl Imagen Mol; 2012; 31(1):44-6. PubMed ID: 21719158
    [No Abstract]   [Full Text] [Related]  

  • 22. Detection of prostate cancer relapse with PET/CT using a novel radiotracer.
    Lilleby W; Willoch F; Stensvold A
    Acta Oncol; 2012 Mar; 51(3):397-9. PubMed ID: 21936756
    [No Abstract]   [Full Text] [Related]  

  • 23. Value of 11C-choline PET/CT for lung cancer diagnosis and the relation between choline metabolism and proliferation of cancer cells.
    Li M; Peng Z; Liu Q; Sun J; Yao S; Liu Q
    Oncol Rep; 2013 Jan; 29(1):205-11. PubMed ID: 23124523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The utility of 11C-choline PET/CT for imaging prostate cancer: a pictorial guide.
    Murphy RC; Kawashima A; Peller PJ
    AJR Am J Roentgenol; 2011 Jun; 196(6):1390-8. PubMed ID: 21606304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distant metastasis of prostate cancer: early detection of recurrent tumor with dual-phase carbon-11 choline positron emission tomography/computed tomography in two cases.
    Maeda T; Tateishi U; Komiyama M; Fujimoto H; Watanabe S; Terauchi T; Moriyama N; Arai Y; Sugimura K; Kakizoe T
    Jpn J Clin Oncol; 2006 Sep; 36(9):598-601. PubMed ID: 16844733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Final analysis of a prospective trial on functional imaging for nodal staging in patients with prostate cancer at high risk for lymph node involvement.
    Van den Bergh L; Lerut E; Haustermans K; Deroose CM; Oyen R; Isebaert S; Budiharto T; Ameye F; Mottaghy FM; Bogaerts K; Van Poppel H; Joniau S
    Urol Oncol; 2015 Mar; 33(3):109.e23-31. PubMed ID: 25655681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic imaging work-up for disease relapse after radical treatment for prostate cancer: how to differentiate local from systemic disease? The urologist point of view.
    Schiavina R; Brunocilla E; Borghesi M; Vagnoni V; Castellucci P; Nanni C; Ceci F; Gacci M; Martorana G; Fanti S
    Rev Esp Med Nucl Imagen Mol; 2013; 32(5):310-3. PubMed ID: 23933383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET.
    de Jong IJ; Pruim J; Elsinga PH; Vaalburg W; Mensink HJ
    J Nucl Med; 2003 Mar; 44(3):331-5. PubMed ID: 12620996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Penile metastases from carcinoma of the prostate.
    Pandian SS; McGuire M; McClinton S; Kerr KM
    Br J Urol; 1997 May; 79(5):807. PubMed ID: 9158527
    [No Abstract]   [Full Text] [Related]  

  • 30. [Detection of second tumors in 11C-choline PET/CT studies performed due to biochemical recurrence of prostate cancer].
    García JR; Ponce A; Canales M; Ayuso J; Moragas M; Soler M
    Rev Esp Med Nucl Imagen Mol; 2014; 33(1):28-31. PubMed ID: 23499124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PET/triphasic contrast enhanced CT: Optimized protocol for the assessment of colorectal liver metastases.
    Domínguez Ferreras E; García Vicente AM; Cano Cano JM; Molino Trinidad C; Soriano Castrejón AM; Espinosa Arrainz J
    Rev Esp Med Nucl Imagen Mol; 2013; 32(5):336-7. PubMed ID: 23583267
    [No Abstract]   [Full Text] [Related]  

  • 32. Incidental 11C-choline PET/CT uptake due to esophageal carcinoma in a patient studied for prostate cancer.
    Bertagna F; Bertoli M; Treglia G; Manenti S; Salemme M; Giubbini R
    Clin Nucl Med; 2014 Oct; 39(10):e442-4. PubMed ID: 24561683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pro and contra: 11C choline PET in diagnosis of prostate cancer].
    Kotzerke J; Zöphel K; Salomon G; Graefen M; Heidenreich A
    Aktuelle Urol; 2007 May; 38(3):189-94. PubMed ID: 17566231
    [No Abstract]   [Full Text] [Related]  

  • 34. FDG PET/CT imaging in prostate adenocarcinoma presenting as isolated brain metastases of unknown origin.
    Erhamamcı S; Reyhan M; Alkan O
    Rev Esp Med Nucl Imagen Mol; 2015; 34(2):146-7. PubMed ID: 25052407
    [No Abstract]   [Full Text] [Related]  

  • 35. 11C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms.
    Schiavina R; Scattoni V; Castellucci P; Picchio M; Corti B; Briganti A; Franceschelli A; Sanguedolce F; Bertaccini A; Farsad M; Giovacchini G; Fanti S; Grigioni WF; Fazio F; Montorsi F; Rigatti P; Martorana G
    Eur Urol; 2008 Aug; 54(2):392-401. PubMed ID: 18456393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 11C-choline PET/CT scan in patients with prostate cancer treated with intermittent ADT: a sequential PET/CT study.
    Ceci F; Schiavina R; Castellucci P; Brunocilla E; Fuccio C; Colletti PM; Ferretti A; Chondrogiannis S; Rubello D; Romagnoli D; Malizia C; Martorana G; Fanti S
    Clin Nucl Med; 2013 Jul; 38(7):e279-82. PubMed ID: 23698461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Value of PET/CT and MR lymphography in treatment of prostate cancer patients with lymph node metastases.
    Fortuin AS; Deserno WM; Meijer HJ; Jager GJ; Takahashi S; Debats OA; Reske SN; Schick C; Krause BJ; van Oort I; Witjes AJ; Hoogeveen YL; van Lin EN; Barentsz JO
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):712-8. PubMed ID: 22417806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imaging prostate cancer with 11C-choline PET/CT.
    Reske SN; Blumstein NM; Neumaier B; Gottfried HW; Finsterbusch F; Kocot D; Möller P; Glatting G; Perner S
    J Nucl Med; 2006 Aug; 47(8):1249-54. PubMed ID: 16883001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic efficacy of [11C]choline positron emission tomography/computed tomography compared with conventional computed tomography in lymph node staging of patients with bladder cancer prior to radical cystectomy.
    Maurer T; Souvatzoglou M; Kübler H; Opercan K; Schmidt S; Herrmann K; Stollfuss J; Weirich G; Haller B; Gschwend JE; Schwaiger M; Krause BJ; Treiber U
    Eur Urol; 2012 May; 61(5):1031-8. PubMed ID: 22196847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 11C-Choline and 18F-FDG PET/CT in the Detection of Occult Prostate Cancer in the Context of a Paraneoplastic Syndrome.
    Jiménez-Bonilla J; Quirce R; Banzo I; Martínez-Rodríguez I; Carril JM
    Clin Nucl Med; 2015 Aug; 40(8):695-6. PubMed ID: 26018697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.